483
Nordmark Arzneimittel GMBH & Co. KGNordmark Arzneimittel GMBH & Co. KG – FDA 483, Feb 13, 2025
Record Details
Nordmark Arzneimittel GMBH & Co. KG, a drug substance manufacturer in Uetersen, Germany, was inspected by the FDA and received four observations. The inspection revealed significant issues with quality unit procedures, including failure to investigate root causes for contamination and deviations, lack of evidence for representative sampling, and non-contemporaneous documentation practices. These findings indicate a need for improved quality control and data integrity.
View Company Profile
ID · 224c37dc-569f-4745-ba9a-33fc53d845e5
Other documents for Nordmark Arzneimittel GMBH & Co. KG
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.